Note: This company is no longer actively listed. Financial data shown is historical.
Showing 2 of 10 years of data. Sign up free for 5 years of history.
View PlansCash Conversion
0.74x
JBCHEPHARM's operating cash flow covered 74% of net income in FY 2026. Some earnings may be tied up in working capital.
Free Cash Flow
₹6.21B
JBCHEPHARM's free cash flow was ₹6.21B in FY 2026, down 22.9% from FY 2025.
Dividend Coverage
2.0x
JBCHEPHARM's free cash flow covered dividends 2.0x in FY 2026 but leaves limited surplus.
Hover the chart icon for YoY change.
| Item | Chart | 2025 | 2026 |
|---|---|---|---|
| Net Income | 8.87B | 9.52B | |
| Cash flow Operating Activities | 9.02B | 7.04B | |
| Investments in PPE | -975.88M | -831.89M | |
| Cash flow Investing Activities | -2.96B | -5.86B | |
| Dividend Paid | -2.37B | -3.13B | |
| Cash flow Financing Activities | -5.80B | -1.23B | |
| Cash at beginning of period | 882.15M | 1.15B | |
| Cash at end of period | 1.15B | 1.10B | |
| Free Cash Flow | 8.05B | 6.21B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026